entertainment -WSS

entertainment

author：hotspot 2025-10-01 00:58:47 - browse：658

A phone screen displays the webpage of Medicare.gov — coverage from STAT — Adobe

Over the past few weeks, Medicare Advantage insurers demanded that the Biden administration give them higher payment rates for next year. The government’s data on how much people were using health care didn’t match their own data, insurers and lobbyists griped — and therefore they wouldn’t be paid enough to cover those costs.

But the federal government was not persuaded by the industry’s data or lobbying push. The Biden administration and its Medicare agency decided to stick with their proposals from January on Monday, dealing a blow to an insurance industry that has come to rely on Medicare Advantage for a steady stream of profits.

The result: In 2025, right after a new president is elected, Medicare Advantage insurers will have to absorb a slight decrease of 0.2% to the baseline payment rates that insurers receive from the government for enrolling older adults and people with disabilities. The stock prices of the largest Medicare Advantage insurers — UnitedHealth, Humana, CVS Health, and Elevance Health — all fell by at least 4% in after-hours trading.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： A new House health package & hospitals’ new site

hotspot

WSS

Medicaid rebukes states for mistakenly disenrolling children

Advances in CAR

Scientists inch closer to single

A new House health package & hospitals’ new site

The high personal cost of affirmative action for Black doctors

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

Wikipedia

entertainment

hotspot

Affirmative action in medical school literally saved lives

5 important ways Henrietta Lacks changed medical science

In age of alternative facts, a scholarly course on calling out crap

Listen: Biogen's situation, Wegovy's risks, & biotech insider trading

State Dept. review finds Biden bears some blame for Afghanistan failures

Sage hopes for a blockbuster in antidepressant now before FDA

Trump demands the U.S. pay no more for drugs than other countries … again

What the airline industry can learn from medicine

How one medical school became remarkably diverse

Listen: Biogen's potential pivot, & Illumina's next chapter

focus

Listen: Biogen's potential pivot, & Illumina's next chapter

Trump indictment: Who are the 'co

Covid hospitalizations on the rise, Humana says

Tire on Delta flight pops while landing in Atlanta, 1 person injured, airline says

House transparency, PBM reform bill gains bipartisan support

Snackable artificial intelligence, expert AI, and the pharma industry

hotspot

focus

leisure time

explore